These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Tibolone and risk of endometrial polyps: a prospective, comparative study with hormone therapy. Perez-Medina T; Bajo-Arenas J; Haya J; Sanfrutos L; Iniesta S; Bueno B; Castelo-Branco C Menopause; 2003; 10(6):534-7. PubMed ID: 14627862 [TBL] [Abstract][Full Text] [Related]
6. Bleeding with menopausal hormone therapy: physiological or pathological? Hickey M Menopause Int; 2007 Dec; 13(4):188-90. PubMed ID: 18088532 [TBL] [Abstract][Full Text] [Related]
7. Endometrial bleeding during hormone therapy: the effect of progestogens. Archer DF Maturitas; 2007 May; 57(1):71-6. PubMed ID: 17412535 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors. Hickey M; Crewe J; Mahoney LA; Doherty DA; Fraser IS; Salamonsen LA J Clin Endocrinol Metab; 2006 Aug; 91(8):3189-98. PubMed ID: 16684831 [TBL] [Abstract][Full Text] [Related]
9. Regulation of estrogen/progestogen receptors in the endometrium. Casper RF Int J Fertil Menopausal Stud; 1996; 41(1):16-21. PubMed ID: 8673152 [TBL] [Abstract][Full Text] [Related]
10. Endometrial bleeding in postmenopausal women: with and without hormone therapy. Archer DF Menopause; 2011 Apr; 18(4):416-20. PubMed ID: 21701426 [TBL] [Abstract][Full Text] [Related]
11. [HRT in post-menopausal women: endometrial histology and bleeding patterns]. Lo Dico G; Alongi G; Spinelli MP; Cannariato P; Lucido AM Minerva Ginecol; 2002 Aug; 54(4):361-6. PubMed ID: 12114870 [TBL] [Abstract][Full Text] [Related]
12. Continuous combined hormone replacement therapy with 1 mg 17beta-oestradiol and 5 mg dydrogesterone (Femoston-conti): endometrial safety and bleeding profile. Quereux C; Pornel B; Bergeron C; Ferenczy A Maturitas; 2006 Feb; 53(3):299-305. PubMed ID: 16043317 [TBL] [Abstract][Full Text] [Related]
13. Comparison of a transdermal continuous combined and an interrupted progestogen HRT. Cameron ST; Glasier AF; Gebbie A; Dewart H; Baird DT Maturitas; 2006 Jan; 53(1):19-26. PubMed ID: 16325020 [TBL] [Abstract][Full Text] [Related]
14. Why does menopausal hormone therapy lead to irregular uterine bleeding? Changes to endometrial blood vessels. Hickey M; Doherty DA; Fraser IS; Sloboda DM; Salamonsen LA Hum Reprod; 2008 Apr; 23(4):912-8. PubMed ID: 18216041 [TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy: aspects of bleeding problems and compliance. Samsioe G Int J Fertil Menopausal Stud; 1996; 41(1):11-5. PubMed ID: 8673151 [TBL] [Abstract][Full Text] [Related]
16. Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability. Hammar ML; van de Weijer P; Franke HR; Pornel B; von Mauw EM; Nijland EA; BJOG; 2007 Dec; 114(12):1522-9. PubMed ID: 17995496 [TBL] [Abstract][Full Text] [Related]